Status:
WITHDRAWN
Intensive Lifestyle Intervention for Type 2 Diabetics: The KP TLC Pilot
Lead Sponsor:
Kaiser Permanente
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine if a healthy lifestyle intervention can significantly improve blood sugar control in type 2 diabetics over a course of 3 months.
Detailed Description
Peer reviewed research studies have proven the benefits of lifestyle interventions including the reversal of coronary artery disease and of diabetes. Experts agree that such a lifestyle must include a...
Eligibility Criteria
Inclusion
- English-speaking patients \> 18 years of age, with at least 6 months of membership, who have type 2 diabetes.
- Patients must have a recent HbA1C lab value \> 8.0, and have had at least 2 previous HbA1C measures during the previous 6-12 months.
- Patients with HbA1C values that are consistently \> 8.0 over the previous 6-12 months will be invited to participate.
Exclusion
- current excessive alcohol use (drinking \> 14 alcohol beverages per week for men or \> 7 per week for women or \> 4 per day for men or \> 2 per day for women on 2 or more occasions each month)
- current use of illegal or street drugs,
- severely decreased functional capacity (shortness of breath or chest pain at rest or with minimal activity), and/or
- suicidal thoughts or depression, will
- Patients with severely limited physical ability
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01484353
Last Update
March 11 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Riverside Medical Center
Riverside, California, United States, 92505